ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 070 JPY -1.33% Market Closed
Market Cap: 58.6B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note

ASKA Pharmaceutical Holdings Co Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ASKA Pharmaceutical Holdings Co Ltd
Net Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Net Income
ÂĄ9.9B
CAGR 3-Years
40%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income
ÂĄ150.1B
CAGR 3-Years
-30%
CAGR 5-Years
71%
CAGR 10-Years
3%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income
ÂĄ295.3B
CAGR 3-Years
55%
CAGR 5-Years
21%
CAGR 10-Years
9%
Otsuka Holdings Co Ltd
TSE:4578
Net Income
ÂĄ146B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Net Income
ÂĄ28.6B
CAGR 3-Years
-38%
CAGR 5-Years
-36%
CAGR 10-Years
-15%

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Net Income?
Net Income
9.9B JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Net Income amounts to 9.9B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's Net Income growth rate?
Net Income CAGR 5Y
39%

Over the last year, the Net Income growth was 84%. The average annual Net Income growth rates for ASKA Pharmaceutical Holdings Co Ltd have been 40% over the past three years , 39% over the past five years .

Back to Top